United States Federal Circuit
Ferring B.V. v. Watson Laboratories, Inc., 14-1377
Dismissal of plaintiff's claims alleging that defendant infringed each and every claim of the patents-in-suit by filing an Abbreviated New Drug Application (ANDA) is affirmed, where defendant's amendment to its ANDA rendered it non-infringing.
Appellate Information
- Decided 08/22/2014
- Published 08/22/2014
Judges
- DYK
Court
- United States Federal Circuit